Nicole Fawcett
Director of Communications, University of Michigan Rogel Cancer

Fawcett leads a team of communicators who produce targeted, innovative communication for the Rogel Cancer Center’s research and clinical enterprises. Prior to Michigan Medicine, Fawcett was a reporter at the Detroit News and editor for a web-based community for people with disabilities.
Rogel Cancer Center building during the day
News Release

Rogel Cancer Center adds 3 new senior leadership roles

The University of Michigan Rogel Cancer has named two new deputy directors and a new associate director to provide strategic leadership in cancer care, research and training: Michael Deininger, M.D., Ph.D.; Lesly Dossett, M.D., M.P.H.; and Samuel Kaffenberger, M.D.
 man looking at camera looking serious hands folded in long blurred hallway behind him
Health Lab

How genetic testing impacts the whole family

Rogel Cancer Center researcher Steven J. Katz, M.D., M.P.H., on how genetic testing results impact both the cancer patient and their family.
 microscopic image with one on left saying untreated and one right saying TCDD treated. They are lit up bright green and some blue and a little red on the right
Health Lab

Study shows how smoking drives pancreatic cancer

Why smokers have a higher chance of developing pancreatic cancer and why they tend to have worse outcomes than nonsmokers, according to a new study by University of Michigan Health Rogel Cancer Center.
 yellow pills spilling out of bottle
Health Lab

Study sheds light on why some prostate tumors are resistant to treatment

A new study from University of Michigan Rogel Cancer Center researchers identifies a cellular signature that explains why about one-third of prostate cancers respond especially poorly to treatment. 
 purple white
Health Lab

Study defines key driver of aggressive ovarian cancer

A study explains the genetic underpinnings of a rare and aggressive form of ovarian cancer – and offers a potential pathway for new treatments.
 pill being taken close up with water near hand
Health Lab

Patients are opting in for 10 years of breast cancer treatment

As recommendations suggest extending hormone-based breast cancer treatment to 10 years for some patients, a recent study sheds light on whether patients are opting for it.
News Release

U-M awarded prestigious NIH grant to establish national center for microsystems-based biomedical imaging

Researchers from the University of Michigan received a $6 million center grant from the National Institutes of Health to establish the new National Center for Biomedical Imaging and Bioengineering (NCBIB).
 cells purple some lighter cells in white
Health Lab

Researchers find early driver of prostate cancer aggressiveness

University of Michigan Health Rogel Cancer Center scientists identified a gene that plays a key role in prostate cancer cells that have transitioned to a more aggressive, treatment-resistant form. The gene can be indirectly targeted with an existing class of drugs, suggesting a potential treatment strategy for patients with aggressive subtypes of prostate cancer.
 Susan and Richard Rogel are standing together behind a table. Susan is leaning over with a pen in her hand to sign a gift agreement. She's smiling and looking at someone out of the frame. Richard is smiling and looking directly at the camera.
Medicine at Michigan

Rogel Cancer Center receives $50M to revolutionize pancreatic cancer care and research

Susan and Richard Rogel have given $50 million to create the Rogel and Blondy Center for Pancreatic Cancer at Michigan Medicine.
 two women hugging with cap over hair
Health Lab

Study offers reassurance for patients with some cancer-linked genes

Research by the University of Michigan Health Rogel Cancer Center finds that patients with three of these variants face no extra risk of dying from their cancer.
Health Lab

4 exciting advances in multiple myeloma

A specialist outlines some recent advances that have him excited for the future of multiple myeloma treatment.
News Release

Rogel names 2 new clinical research leaders

Cuneo appointed associate director for clinical research; Magenau to serve in new assistant director role
 patient looking at paper with provider in scrubs blue in clinic
Health Lab

How race impacts patients’ response to cancer immunotherapy

The first large scale analysis finds immune checkpoint inhibitors are equally effective in Black and white patients, with Black patients having fewer side effects.
 close up of orange and purple squiggle-looking cells merging and a little green in the middle
Health Lab

Researchers find metabolic mechanism that blocks immune response, immunotherapy in cancer

New research has discovered why some cancers don’t respond to immunotherapy treatment: A metabolite transporter within the tumor microenvironment blocks a key type of tumor cell death integral to immune response.
 Susan and Richard Rogel pose next to a grand piano. Rogel is wearing a polo shirt with a block M.
News Release

Rogel Cancer Center receives $50M gift to revolutionize pancreatic cancer care, research

New Rogel and Blondy Center for Pancreatic Cancer will bring together researchers and clinicians to drive forward new treatments and improve outcomes
  • 1
  • 2
  • 3
    •